OCERA THERAPEUTICS
Ocera is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet medical need. Ocera's HE clinical development efforts include a recently completed Phase 2b clinical trial, STOP-HE, which evaluated the safety and efficacy of intravenously-administered OCR-002 in resolving neurocognitive symptoms of acute HE in hospitalized patients with elevated ammonia. Ocera is preparing to meet with the FDA later this year to review the IV program and discuss potential development paths forward.
OCERA THERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2005-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.ocerainc.com
Total Employee:
11+
Status:
Closed
Contact:
650-475-0158
Total Funding:
97 M USD
Technology used in webpage:
SPF SSL By Default Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS IIS 10 Proofpoint Entrust EV Entrust SSL
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Civitas Therapeutics
Civitas Therapeutics is a biopharmaceutical company that focuses on developing pulmonary delivery therapies.
Moerae Matrix
Moerae Matrix is a biopharmaceutical company developing targeted therapeutics for fibrotic diseases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
SpringWorks Therapeutics
SpringWorks Therapeutics is a biopharmaceutical company focused on developing medicines for patients with severe rare diseases and cancer.
Transition Therapeutics
Transition Therapeutics is a biopharmaceutical company developing novel therapeutics for disease indications with large markets.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Ocera Therapeutics
Greenspring Associates
Greenspring Associates investment in Post-IPO Debt - Ocera Therapeutics
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Ocera Therapeutics
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Ocera Therapeutics
Venrock
Venrock investment in Post-IPO Equity - Ocera Therapeutics
Deerfield Partners
Deerfield Partners investment in Post-IPO Equity - Ocera Therapeutics
Vivo Capital
Vivo Capital investment in Post-IPO Equity - Ocera Therapeutics
Three Arch Partners
Three Arch Partners investment in Post-IPO Equity - Ocera Therapeutics
InterWest Partners
InterWest Partners investment in Post-IPO Equity - Ocera Therapeutics
Great Point Partners
Great Point Partners investment in Post-IPO Equity - Ocera Therapeutics
Official Site Inspections
http://www.ocerainc.com
- Host name: ocerainc.com
- IP address: 146.214.1.28
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
